barts-ms coronavirus antibody study
Published 3 years ago • 264 plays • Length 10:42Download video MP4
Download video MP3
Similar videos
-
57:37
prof gavin giovannoni: managing ms remotely during the covid-19 pandemic
-
1:10:34
ms and covid-19 what we have learned so far - prof gavin giovannoni
-
1:00:22
anti-cd20 therapies and covid-19 | ms academy
-
1:06:28
update of covid-19 and ms – morbidity and mortality figures | ms academy
-
38:43
professor gavin giovannoni discusses brain health and the importance of the brain health message
-
1:09:42
vaccination – will our patients be able to respond to a coronavirus vaccine? | ms academy
-
47:06
barts-ms journal club 28 oct 2020
-
5:17
1/10 what is multiple sclerosis? | professor gavin giovannoni
-
56:03
ms variance '19 – lifelong brain health as a target for ms service provision (prof gavin giovannoni)
-
58:32
how to prepare in the event of you getting covid-19 | ms academy #mscovid19
-
9:47
ms drug safety (covid-19/coronavirus) analysis by experts (giovannoni, waubant)
-
52:51
barts-ms journal club ide smets on ris - 2
-
19:15
covid-19 and the impact on ms rehabilitation in the covid-19 era
-
49:25
barts-ms journal club saul reyes 9th-sept-2020
-
26:20
preserving brain health in time of covid-19
-
50:23
pregnancy – what should we advise our patients during the covid-19 pandemic? | ms academy
-
10:21
additional insights from natalizumab treatment in ms
-
43:44
barts ms journal club 26 jan 2021 ide smets ofatumumab vs teriflunomide
-
4:41
6/10 treatment strategies in multiple sclerosis | professor gavin giovannoni